Date published: 2025-12-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

9(S)-HODE-d4 (CAS 98524-19-7 (unlabeled))

0.0(0)
Write a reviewAsk a question

CAS Number:
98524-19-7 (unlabeled)
Molecular Weight:
300.5
Molecular Formula:
C18H28D4O3
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

9(S)-HODE-d4, with the CAS number 98524-19-7, is a deuterated form of 9(S)-hydroxyoctadecadienoic acid (9(S)-HODE), a primary oxidation product of linoleic acid and a member of the hydroxyoctadecadienoic acids. The introduction of four deuterium atoms in place of hydrogen enhances the molecular stability and detectability of this compound, making it particularly useful in sophisticated analytical studies such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. In research, 9(S)-HODE-d4 serves as an important tool for investigating the detailed metabolic pathways of lipid oxidation and the biological roles of 9(S)-HODE. This molecule participates in the modulation of diverse biological processes, including cell signaling and the regulation of inflammatory responses. Studies utilizing 9(S)-HODE-d4 focus on its formation from linoleic acid through enzymatic pathways involving lipoxygenases, and its subsequent interactions with specific receptors and signaling molecules within cells. This research helps in understanding the complex dynamics of lipid peroxidation products in cellular environments and their potential roles in regulating cellular functions and responses to oxidative stress. The use of the deuterated version allows researchers to trace and quantify the dynamics of these interactions with greater precision, providing clearer insights into the bioactive mechanisms of lipid mediators.


9(S)-HODE-d4 (CAS 98524-19-7 (unlabeled)) References

  1. Lethal dysregulation of energy metabolism during embryonic vitamin E deficiency.  |  McDougall, M., et al. 2017. Free Radic Biol Med. 104: 324-332. PMID: 28095320
  2. Vitamin E deficiency during embryogenesis in zebrafish causes lasting metabolic and cognitive impairments despite refeeding adequate diets.  |  McDougall, M., et al. 2017. Free Radic Biol Med. 110: 250-260. PMID: 28645790
  3. Specialized Pro-Resolving Lipid Mediators Regulate Ozone-Induced Pulmonary and Systemic Inflammation.  |  Kilburg-Basnyat, B., et al. 2018. Toxicol Sci. 163: 466-477. PMID: 29471542
  4. Trisomy 21 impairs PGE2 production in dermal fibroblasts.  |  Marentette, JO., et al. 2021. Prostaglandins Other Lipid Mediat. 153: 106524. PMID: 33418267
  5. Novel Mechanisms of Ozone-Induced Pulmonary Inflammation and Resolution, and the Potential Protective Role of Scavenger Receptor BI.  |  Gowdy, KM., et al. 2021. Res Rep Health Eff Inst. 2021: 1-49. PMID: 33998222
  6. Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects.  |  Johnson, RK., et al. 2022. J Allergy Clin Immunol. 150: 965-971.e8. PMID: 35304161
  7. Profiling the oxylipidome in aged mice after chronic ethanol feeding: Identifying lipid metabolites as drivers of hepatocyte stress.  |  Anton, PE., et al. 2023. Alcohol. 107: 119-135. PMID: 36150611
  8. AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120.  |  Yan, CH., et al. 2022. Nat Commun. 13: 7721. PMID: 36513627
  9. Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis.  |  Broos, JY., et al. 2023. Neurology. 101: e533-e545. PMID: 37290971
  10. A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation.  |  League, AF., et al. 2024. Front Immunol. 15: 1374301. PMID: 38835765

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

9(S)-HODE-d4, 25 µg

sc-221174
25 µg
$142.00

9(S)-HODE-d4, 50 µg

sc-221174A
50 µg
$270.00